Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ASAC Pharma is a Spanish pharmaceutical group specializing in the development, manufacture, and commercialization of products for allergy, respiratory, and musculoskeletal health. Founded on the expertise of a scientific collective, the company is a leader in allergen-specific immunotherapy (vaccines) and diagnostic tools, primarily operating through its specialized subsidiary, Diater. The group maintains a diverse portfolio that includes prescription medicines, dermo-cosmetics, and chondroprotectors for joint health. With a strong international presence, ASAC Pharma operates production facilities in Spain and Brazil, distributing its healthcare solutions across Europe, Latin America, and North Africa.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Associated Scientists to Help Minimize Allergies.